Waage Christian

Companies

• Gossamer Bio, Inc.EVP, Tech Ops and Admin Mar 24, 2022 to now¹
• HERON THERAPEUTICS, INC. /DE/Board member Jun 23, 2016 to now²
• Gossamer Bio, Inc.General counsel Feb 7, 2019 to Jan 10, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GBGossamer Bio, Inc. GOSS836,283 shares⁴$7.2M at $8.56Jan 5, 2026
• HTHERON THERAPEUTICS, INC. /DE/ HRTX53,960 shares⁵$18.9K at $0.35Jan 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 30, 2026Granted 53,960 shares of HERON THERAPEUTICS, INC. /DE/⁵
• Jan 2, 2026Granted 84,500 shares of Gossamer Bio, Inc.⁴
• Oct 1, 2025Granted 125,000 shares of Gossamer Bio, Inc.⁶
• Jan 31, 2025Granted 17,950 shares of HERON THERAPEUTICS, INC. /DE/⁷
• Jan 30, 2025Granted 17,950 shares of HERON THERAPEUTICS, INC. /DE/⁸
• Mar 27, 2024Sold 6,430 shares at $1.16 of Gossamer Bio, Inc.⁹
• Jan 19, 2024Granted 13,948 shares of HERON THERAPEUTICS, INC. /DE/¹⁰
• Jul 24, 2023Granted 13,504 shares at $1.82 of Gossamer Bio, Inc.¹¹
• Mar 20, 2023Bought 18,500 shares at $1.20 of Gossamer Bio, Inc.¹²
• Dec 16, 2022Granted 38,580 shares of HERON THERAPEUTICS, INC. /DE/¹³
• Jul 15, 2022Bought 6,934 shares at $7.21 of Gossamer Bio, Inc.¹⁴
• Mar 23, 2022Sold 10,722 shares at $8.92 of Gossamer Bio, Inc.¹⁵
• Dec 22, 2021Granted 10,452 shares of HERON THERAPEUTICS, INC. /DE/¹⁶
• Dec 21, 2021Sold 300 shares at $9.73 of HERON THERAPEUTICS, INC. /DE/¹⁶